glp-1 autoinjector Understanding Diabetes Drugs and Diabetes Eli Lilly's New $299 Month-Long

A 2026 UCL study published in BMC Medicine found that around 1.6 million adults in England, Wales, and Scotland used a GLP-1 weight-loss drug in the year to early 2025

Type 2 diabetes mellitus represents more than 85% of all diabetes cases globally

Reference: Gheysari, R., Nikbaf-Shandiz, M., Hosseini, A.M

Priority Review designation is possible given the magnitude of the trial results, which could shorten this timeline to 6 months

The 23G x 1.25 you have should be fine to use

According to the company, the monthly subscription price includes all evaluations, follow-ups, medication, and shipping with no hidden fees